Renaxen

Sobre este medicamento

Originator: Inlyta/ AG-013736 by Pfizer · Manufacturer: Everest Pharma. Indication & Dosage: Renaxen (Axitinib), generic Inlyta is a prescription medicine used to treat advanced renal cell carcinoma (RCC). Axitinib uses for inhibiting tumor growth. Axitinib inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF). Renaxen manufactured by Everest Pharma Ltd. in Bangladesh. Axitinib has to take orally twice daily with/ without food. Side Effects: The most common adverse reactions of Axitinib are: Diarrhea , nausea , vomiting , loss of appetite , dizziness , tiredness / weakness , temporary hair loss , weight loss, cough, headache, altered sense of taste, hoarseness, constipation, or upset stomach. The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.